Last reviewed · How we verify
Influenza prevention — Treatment Landscape & Competitive Intelligence
3 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Assorted Licensed Hand Sanitizer Grape 01 | Licensed influenza vaccine | Pfizer | vaccine | unknown | ||
| Licensed Influenza Vaccine 2 | Licensed Influenza Vaccine 2 | BioNTech | Vaccine | Not specified | ||
| Qiv | qiv | Pfizer | Inactivated vaccine | Influenza viruses |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Pfizer · 2 drugs in Influenza prevention
- BioNTech · 1 drug in Influenza prevention
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Influenza prevention:
- Influenza prevention treatment updates — RSS
- Influenza prevention treatment updates — Atom
- Influenza prevention treatment updates — JSON
Cite this brief
Drug Landscape (2026). Influenza prevention — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/influenza-prevention. Accessed 2026-06-10.
Related
- Influenza prevention full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing